Stock Research Report for Morepen Laboratories Ltd
Stock score of Morepen Laboratories Ltd moved up by 2 in 3 months on a 10 point scale (Source: Refinitiv). Get detailed report on Morepen Laboratories Ltd by subscribing to ETPrime.
Get 4000+ Stock Reports worth₹ 1,499* with ETPrimeat no extra cost for you
*As per competitive benchmarking of annual price. T&C apply
Make Investment decisions
with proprietary stock scores on earnings, fundamentals, relative valuation, risk and price momentum
Find new Trading ideas
with weekly updated scores and analysts forecasts on key data points
In-Depth analysis
of company and its peers through independent research, ratings, and market data
Morepen Laboratories Limited is a pharmaceutical company. The Company's divisions include Active Pharmaceutical Ingredients (API), Home Diagnostics and Finished Formulations. The API division offers products, such as Loratadine Process-1, Desloratadine, Atorvastatin Calcium Amorphous, Atorvastatin Calcium Crystalline Form VI and Linagliptin, among others. The Company offers products under the self-health diagnostic brand HomeHealth. Its HomeHealth portfolio includes automatic digital blood pressure monitors, digital and analog weighing scales, body and foot massagers, heat therapy range, nebulizers, pregnancy cards, and clinical and digital thermometers. The Company offers no coding blood glucose monitoring system under its brand, GlucoOne. It markets various brands of medical devices and clinical diagnostic products. The Company operates in India, the United States and Rest of World. Its subsidiaries include Dr. Morepen Limited, Total Care Limited and Morepen Inc.
